GE Healthcare Pharma and Medical Expert Collaboration
On March 16, 2026, GE Healthcare Pharma Inc., based in Minato Ward, Tokyo, and Medical Expert Inc., headquartered in Chuo Ward, Tokyo, announced a key agreement to commence sales of the CT motion™, a contrast agent injector manufactured by the German company, Ulrich. The product will be launched in Japan on April 1, 2026.
CT motion™ stands out as the flagship product of Ulrich, integrating automated, syringe-free technology. This innovative design minimizes preparation tasks associated with CT contrast examinations, thereby streamlining workflows and enhancing operational efficiency within medical facilities. Additionally, by optimizing the amount of contrast agent used, the device contributes to reducing waste, significantly lowering environmental impact.
Etsumi Fukudome, President of GE Healthcare Pharma, expressed his enthusiasm stating, "We aim to bring the technical merits of CT motion™ to medical settings in Japan, addressing environmental challenges related to medical resources. Our goal is to position this product as a vital option that harmonizes quality healthcare with sustainability."
Further underscoring the importance of this partnership, Nobuyuki Kaneko, President of Medical Expert, remarked, "We are thrilled that our companies can deliver CT motion™ to Japan's healthcare landscape. Leveraging our extensive experience in equipment support, we are committed to promoting the dual principles of efficiency and sustainability to a broader range of medical institutions."
As healthcare environments face fluctuations in the supply of contrast agents, there is a pressing need to utilize limited medical resources effectively, providing optimal diagnoses and treatments for patients. Recently, the importance of minimizing environmental footprint within radiology has gained significant traction, leading to wider adoption of initiatives such as "Sustainable Radiology."
The introduction of CT motion™, which facilitates effective use of contrast agents while promoting efficient workflows, aligns perfectly with this initiative. By delivering this groundbreaking product to healthcare settings, both GE Healthcare Pharma and Medical Expert take a substantial step towards enhancing medical practices sustainably.
Product Information
In addition, the following details regarding device names, approval names, and medical device approval numbers are provided:
| Product Name | Approval Name | Medical Device Approval Number |
|---|
| ----- | --------- | -------- |
| CT motion Spicy | Automated Contrast Agent Injector CT motion | 228AABZX00034000 |
| Patient Hose | Infusion Set | 22800BZX00221000 |
| Pump Tube | Pump Tube | 306AABZX00043000 |
About GE Healthcare Pharma
GE Healthcare Pharma is a leading innovator in diagnostic technology aimed at achieving precision care, in line with GE Healthcare’s global strategy. The company is dedicated to developing, manufacturing, and supplying contrast agents for imaging diagnostics, supporting advanced imaging techniques such as CT, MRI, nuclear medicine, and ultrasound. In the Japanese market, GE Healthcare Pharma emphasizes safety and quality, continually enhancing its stable supply infrastructure to ensure the provision of reliable contrast agent solutions and high-quality healthcare. For more information, please visit
GE Healthcare’s website.
About Medical Expert
Medical Expert Inc. is dedicated to rigorous quality and safety management of medical devices, consistently striving to provide high-quality services recognized by domestic and international manufacturers and hospitals. To improve efficiency in medical settings, the company began domestic sales of the Ulrich CT motion™ product in 2020. This injector utilizes contrast agents from bottles (vials), enabling effective use of these agents and helping to reduce medical waste. By introducing this innovative product, Medical Expert aims to alleviate economic and physical burdens on hospitals and patients, contributing to the realization of higher quality healthcare.
Contact Information
For further inquiries related to this matter:
GE Healthcare Pharma Inc.
Phone: 0120-241-454